THYROSCOPE Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 28

Employees

  • Latest Deal Type
  • Early Stage VC
  • (Cancelled)

  • Latest Deal Amount
  • $10M

  • Investors
  • 13

THYROSCOPE General Information

Description

Developer of artificial intelligence-based medical devices designed to monitor and diagnose thyroid diseases. The company's technology utilizes biosignals from wearable devices to analyze the correlation between heart rate and hormone levels and employs image processing to detect ophthalmic complications, enabling patients with thyroid disease to monitor their condition at home and identify early signs of eye complications through smartphone photography.

Contact Information

Website
www.thyroscope.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 2204, 22nd Floor Tower The Most, Ujeong Innovation City
  • 313 Jongga-ro, Jung-gu
  • Ulsan, Ujeong-dong 44538
  • South Korea
+82
Primary Industry
Decision/Risk Analysis
Other Industries
Diagnostic Equipment
Monitoring Equipment
Vertical(s)
Digital Health, Wearables & Quantified Self, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • Room 2204, 22nd Floor Tower The Most, Ujeong Innovation City
  • 313 Jongga-ro, Jung-gu
  • Ulsan, Ujeong-dong 44538
  • South Korea
+82

THYROSCOPE Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

THYROSCOPE Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Early Stage VC $10M Cancelled Generating Revenue
10. Accelerator/Incubator Completed Generating Revenue
9. Early Stage VC (Series A) 21-Oct-2024 Completed Generating Revenue
8. Accelerator/Incubator 25-Apr-2024 Completed Generating Revenue
7. Accelerator/Incubator Completed Generating Revenue
6. Accelerator/Incubator Completed Generating Revenue
5. Accelerator/Incubator 09-May-2022 Completed Generating Revenue
4. Early Stage VC 01-Apr-2021 Completed Generating Revenue
3. Grant 01-Nov-2020 $13.8K Completed Startup
2. Accelerator/Incubator Completed Startup
To view THYROSCOPE’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

THYROSCOPE Patents

  • 104

    Total Documents Applications and Grants

  • Total Patents Families

  • 51

    Granted

  • 40

    Pending

  • Expiring in next 12 mo

THYROSCOPE Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4606296-A1 Method for estimating exophthalmometric value, and system for performing same Pending 12-Jan-2024
EP-4606296-A4 Method for estimating exophthalmometric value, and system for performing same Pending 12-Jan-2024
WO-2025151008-A1 Method for estimating exophthalmometric value, and system for performing same Inactive 12-Jan-2024
US-12539037-B2 Method for estimating eye protrusion value, and system for performing same Active 12-Jan-2024
US-20250228451-A1 Method for estimating eye protrusion value, and system for performing same Active 12-Jan-2024 A61B3/10
To view THYROSCOPE’s complete patent history, request access »

THYROSCOPE Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

THYROSCOPE Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Inlight Ventures Venture Capital Minority
Insight Equity Partners Venture Capital Minority
KDB Asset Management Asset Manager Minority
Korea Credit Guarantee Fund Venture Capital Minority
Matter (Consulting Services (B2B)) Accelerator/Incubator Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

THYROSCOPE FAQs

  • When was THYROSCOPE founded?

    THYROSCOPE was founded in 2020.

  • Where is THYROSCOPE headquartered?

    THYROSCOPE is headquartered in Ulsan, South Korea.

  • What is the size of THYROSCOPE?

    THYROSCOPE has 28 total employees.

  • What industry is THYROSCOPE in?

    THYROSCOPE’s primary industry is Decision/Risk Analysis.

  • Is THYROSCOPE a private or public company?

    THYROSCOPE is a Private company.

  • What is THYROSCOPE’s current revenue?

    The current revenue for THYROSCOPE is .

  • How much funding has THYROSCOPE raised over time?

    THYROSCOPE has raised $3.07M.

  • Who are THYROSCOPE’s investors?

    Inlight Ventures, Insight Equity Partners, KDB Asset Management, Korea Credit Guarantee Fund, and Matter (Consulting Services (B2B)) are 5 of 13 investors who have invested in THYROSCOPE.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process